GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanxi Jinbo Bio pharmaceutical Co Ltd (BJSE:832982) » Definitions » EV-to-Revenue

Shanxi Jinbo Bio pharmaceutical Co (BJSE:832982) EV-to-Revenue : 14.55 (As of Jun. 25, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Shanxi Jinbo Bio pharmaceutical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Shanxi Jinbo Bio pharmaceutical Co's enterprise value is ¥12,768.8 Mil. Shanxi Jinbo Bio pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥877.7 Mil. Therefore, Shanxi Jinbo Bio pharmaceutical Co's EV-to-Revenue for today is 14.55.

The historical rank and industry rank for Shanxi Jinbo Bio pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

BJSE:832982' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.73   Med: 8.94   Max: 88.82
Current: 15.01

During the past 11 years, the highest EV-to-Revenue of Shanxi Jinbo Bio pharmaceutical Co was 88.82. The lowest was 2.73. And the median was 8.94.

BJSE:832982's EV-to-Revenue is ranked worse than
62.5% of 1032 companies
in the Biotechnology industry
Industry Median: 7.65 vs BJSE:832982: 15.01

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-25), Shanxi Jinbo Bio pharmaceutical Co's stock price is ¥148.02. Shanxi Jinbo Bio pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥13.26. Therefore, Shanxi Jinbo Bio pharmaceutical Co's PS Ratio for today is 11.17.


Shanxi Jinbo Bio pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Shanxi Jinbo Bio pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi Jinbo Bio pharmaceutical Co EV-to-Revenue Chart

Shanxi Jinbo Bio pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.94 8.32 6.29 3.94 22.46

Shanxi Jinbo Bio pharmaceutical Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.67 2.95 18.10 22.46 16.75

Competitive Comparison of Shanxi Jinbo Bio pharmaceutical Co's EV-to-Revenue

For the Biotechnology subindustry, Shanxi Jinbo Bio pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanxi Jinbo Bio pharmaceutical Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanxi Jinbo Bio pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shanxi Jinbo Bio pharmaceutical Co's EV-to-Revenue falls into.



Shanxi Jinbo Bio pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shanxi Jinbo Bio pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=12768.826/877.7
=14.55

Shanxi Jinbo Bio pharmaceutical Co's current Enterprise Value is ¥12,768.8 Mil.
Shanxi Jinbo Bio pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥877.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanxi Jinbo Bio pharmaceutical Co  (BJSE:832982) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shanxi Jinbo Bio pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=148.02/13.257
=11.17

Shanxi Jinbo Bio pharmaceutical Co's share price for today is ¥148.02.
Shanxi Jinbo Bio pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥13.26.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanxi Jinbo Bio pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanxi Jinbo Bio pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanxi Jinbo Bio pharmaceutical Co (BJSE:832982) Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Jinbo Street, Tanghuai Park, Comprehensive Reform Demonstration Zone, Shanxi, Taiyuan, CHN, 030032
Shanxi Jinbo Bio pharmaceutical Co Ltd is engaged in research & development, production and sales of various medical devices and functional skin care products with recombinant collagen products and anti-HPV biological protein products as the core.

Shanxi Jinbo Bio pharmaceutical Co (BJSE:832982) Headlines

No Headlines